Baker Bros Advisors LP Holding in Chemocentryx (CCXI) Trimmed by $2.07 Million; As Thor Industries (THO) Share Value Rose, Penobscot Investment Management Company Has Cut by $510,765 Its Holding

Thor Industries, Inc. (NYSE:THO) Logo

Baker Bros Advisors Lp decreased its stake in Chemocentryx Inc. (CCXI) by 50% based on its latest 2018Q4 regulatory filing with the SEC. Baker Bros Advisors Lp sold 207,000 shares as the company’s stock rose 6.99% with the market. The hedge fund held 207,029 shares of the health care company at the end of 2018Q4, valued at $2.26 million, down from 414,029 at the end of the previous reported quarter. Baker Bros Advisors Lp who had been investing in Chemocentryx Inc. for a number of months, seems to be less bullish one the $505.76 million market cap company. The stock decreased 1.48% or $0.15 during the last trading session, reaching $10.01. About 170,627 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 12.22% since March 9, 2018 and is uptrending. It has outperformed by 7.85% the S&P500. Some Historical CCXI News: 09/05/2018 – CHEMOCENTRYX INC – EXPECTS TO UTILIZE CASH AND INVESTMENTS BETWEEN $65 MLN AND $75 MLN FOR TWELVE MONTHS ENDING DECEMBER 31, 2018; 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 09/03/2018 – ChemoCentryx 4Q Net $39.7M; 09/03/2018 – CHEMOCENTRYX SEES 2018 CASH & INVESTMENTS USE $65M-$75M; 09/03/2018 – ChemoCentryx Expects to Utilize Between $65M-$75M Cash and Investments in FY18; 09/03/2018 ChemoCentryx 4Q EPS 80c; 11/04/2018 – ChemoCentryx Announces Presentation During National Kidney Foundation 2018 Spring Clinical Meeting; 20/04/2018 – DJ Chemocentryx Inc, Inst Holders, 1Q 2018 (CCXI); 09/05/2018 – ChemoCentryx 1Q Loss/Shr 19c; 22/03/2018 – ChemoCentryx Publishes Novel Findings of Role of CCR2 in Kidney Glomerulus, Supporting Advancement of CCR2 Inhibitor CCX140 in the Treatment of Focal Segmental Glomerulosclerosis (FSGS)

Penobscot Investment Management Company Inc decreased its stake in Thor Industries Inc (THO) by 69.33% based on its latest 2018Q4 regulatory filing with the SEC. Penobscot Investment Management Company Inc sold 10,015 shares as the company’s stock rose 0.26% with the market. The institutional investor held 4,430 shares of the consumer non-durables company at the end of 2018Q4, valued at $230,000, down from 14,445 at the end of the previous reported quarter. Penobscot Investment Management Company Inc who had been investing in Thor Industries Inc for a number of months, seems to be less bullish one the $3.50B market cap company. The stock increased 0.38% or $0.24 during the last trading session, reaching $63.55. About 865,946 shares traded. Thor Industries, Inc. (NYSE:THO) has declined 46.27% since March 9, 2018 and is downtrending. It has underperformed by 50.64% the S&P500.

Penobscot Investment Management Company Inc, which manages about $361.63 million and $416.43 million US Long portfolio, upped its stake in Cvs Health Corp (NYSE:CVS) by 6,190 shares to 64,795 shares, valued at $4.25 million in 2018Q4, according to the filing. It also increased its holding in Nextera Energy Inc (NYSE:NEE) by 4,600 shares in the quarter, for a total of 60,757 shares, and has risen its stake in Church & Dwight Co Inc (NYSE:CHD).

Since October 9, 2018, it had 3 insider buys, and 2 selling transactions for $56,798 activity. Another trade for 5,000 shares valued at $408,700 was bought by ZIEMER JAMES L. SUWINSKI JAN bought $116,390 worth of stock. ORTHWEIN PETER BUSCH also sold $350,114 worth of Thor Industries, Inc. (NYSE:THO) shares.

More notable recent Thor Industries, Inc. (NYSE:THO) news were published by: Valuewalk.com which released: “It’s Your Lucky Day – Whitney Tilson Has A Job Offer And A New Stock Idea – ValueWalk” on February 20, 2019, also Seekingalpha.com with their article: “Buying Thor Industries – Seeking Alpha” published on December 16, 2018, Benzinga.com published: “10 Stocks To Watch For March 6, 2019 – Benzinga” on March 06, 2019. More interesting news about Thor Industries, Inc. (NYSE:THO) were released by: Streetinsider.com and their article: “Pre-Open Stock Movers 03/06: (ANF) (ZAYO) (AMBA) Higher; (VLRX) (CLDX) (PRMW) Lower (more…) – StreetInsider.com” published on March 06, 2019 as well as Benzinga.com‘s news article titled: “Earnings Scheduled For March 6, 2019 – Benzinga” with publication date: March 06, 2019.

Investors sentiment decreased to 0.85 in 2018 Q4. Its down 0.16, from 1.01 in 2018Q3. It turned negative, as 69 investors sold THO shares while 110 reduced holdings. 47 funds opened positions while 105 raised stakes. 45.57 million shares or 4.08% more from 43.79 million shares in 2018Q3 were reported. Cwm Lc owns 176 shares. Voya Management Limited Co invested in 31,659 shares. Gendell Jeffrey L holds 0.21% of its portfolio in Thor Industries, Inc. (NYSE:THO) for 21,792 shares. 544,009 were reported by Geode Capital Mngmt Ltd Liability Com. Bogle Invest Mngmt Lp De accumulated 249,266 shares. 1.12 million were reported by Southernsun Asset Management Ltd Liability Corp. Citadel Advsr Ltd Limited Liability Company reported 0% stake. Caisse De Depot Et Placement Du Quebec accumulated 25,800 shares. Cubist Systematic Strategies Ltd Liability Company reported 40,317 shares. Public Employees Retirement Association Of Colorado has 10,267 shares for 0% of their portfolio. Nebraska-based Ameritas Inv Prtn has invested 0.04% in Thor Industries, Inc. (NYSE:THO). Anderson Hoagland &, a Missouri-based fund reported 8,230 shares. Westpac Banking Corp reported 101,800 shares. Gotham Asset Management Ltd Liability Com holds 0.14% or 170,870 shares. Invesco Ltd has 314,407 shares for 0.01% of their portfolio.

Baker Bros Advisors Lp, which manages about $8.20 billion and $12.21B US Long portfolio, upped its stake in Zymeworks Inc. by 397,387 shares to 1.71M shares, valued at $25.08M in 2018Q4, according to the filing. It also increased its holding in Neurocrine Biosciences Inc. (Prn) by 43.27M shares in the quarter, for a total of 53.27M shares, and has risen its stake in Aeglea Biotherapeutics Inc..

Since October 16, 2018, it had 0 buys, and 8 insider sales for $87.64 million activity. Schall Thomas J. sold $447,092 worth of ChemoCentryx, Inc. (NASDAQ:CCXI) on Thursday, January 10. $457,747 worth of ChemoCentryx, Inc. (NASDAQ:CCXI) was sold by KANAYA SUSAN M. Shares for $85.85M were sold by GLAXOSMITHKLINE PLC on Tuesday, October 16.

Investors sentiment decreased to 0.93 in 2018 Q4. Its down 0.05, from 0.98 in 2018Q3. It fall, as 7 investors sold CCXI shares while 38 reduced holdings. 18 funds opened positions while 24 raised stakes. 27.13 million shares or 1.23% more from 26.80 million shares in 2018Q3 were reported. 333,917 were accumulated by Geode Capital Mngmt Ltd Company. Zebra Capital Mgmt Ltd Liability Company holds 0.1% or 14,396 shares in its portfolio. National Bank Of Ny Mellon owns 139,805 shares. Invesco Limited reported 0% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI). Barclays Public Ltd Com has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Northern Trust Corporation has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Bb&T Limited Liability stated it has 114,827 shares or 0.01% of all its holdings. J Goldman Lp holds 0.04% in ChemoCentryx, Inc. (NASDAQ:CCXI) or 45,500 shares. The Quebec – Canada-based Sectoral Asset Management has invested 0.03% in ChemoCentryx, Inc. (NASDAQ:CCXI). 46,700 were accumulated by Alliancebernstein Lp. State Street Corp reported 487,355 shares. Moreover, Matarin Management Lc has 0% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 81,534 shares. The Switzerland-based Credit Suisse Ag has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Paw Capital holds 0.68% or 50,000 shares in its portfolio. Proshare Advsrs Limited Liability Corporation has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI).

More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Globenewswire.com which released: “ChemoCentryx Announces Proposed Public Offering of Common Stock – GlobeNewswire” on September 26, 2018, also Globenewswire.com with their article: “New Research: Key Drivers of Growth for Ellie Mae, Spotify Technology SA, Bristow Group, Teradata, ChemoCentryx, and AgroFresh Solutions — Factors of Influence, Major Initiatives and Sustained Production – GlobeNewswire” published on February 26, 2019, Globenewswire.com published: “ChemoCentryx Reports Third Quarter 2018 Financial Results and Recent Highlights – GlobeNewswire” on November 08, 2018. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Globenewswire.com and their article: “ChemoCentryx Reports Second Quarter 2018 Financial Results and Recent Highlights – GlobeNewswire” published on August 09, 2018 as well as Seekingalpha.com‘s news article titled: “ChemoCentryx: Discounted, Underfollowed, And Misunderstood Biotech – Seeking Alpha” with publication date: May 07, 2018.

Thor Industries, Inc. (NYSE:THO) Institutional Positions Chart


Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.



Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *